LEI: 549300XVXU6S7PLCL855
For immediate release
2 July 2026
Liontrust Asset Management Plc
("Liontrust" or the "Company")
Notification of Admission of Further Securities to Trading (PRM 1.6.4R)
Notification of Admission of Further Securities to Trading (PRM 1.6.4R)
On 1 July 2026, the Company's announced the issue and allotment of new Ordinary Shares to River Global PLC in connection with the completion of the purchase of River Global Holdings Limited on 30 June 2026. Following the admission to trading of those new Ordinary Shares, the following additional information is disclosed in accordance with The Public Offers and Admissions to Trading Regulations 2024 (POATRs) PRM 1.6.4R.
1 Details of the issuer | a) Name Liontrust Asset Management Plc | b) LEI 549300XVXU6S7PLCL855 | 2 Details of the transferable securities admitted to trading | a) Name, type and identification code Ordinary Shares of 1p each; ISIN: GB0007388407 | b) Regulated market London Stock Exchange - Main Market | c) Number of further securities admitted 2,970,232 | d) Total number of securities in issue following admission 62,970,315 | e) Fungibility Fully fungible with existing Ordinary Shares | 3 Admission details | a) Date of admission 1 July 2026 | b) Prospectus information Prospectus: N/A Supplementary: N/A Company's website:www.liontrust.com | c) Coverage of notification The admission on 1 July 2026 |
For further information please contact:
Liontrust Asset Management Plc (Tel: 020 7412 1700, Website: liontrust.com)
Stephen Corbett: Head of Investor Relations
Simon Hildrey: Chief Marketing Officer
Singer Capital Markets (Tel: 020 7496 3000)
Corporate Broking: Charles Leigh-Pemberton
Corporate Advisory: James Moat
Panmure Liberum (Tel: 020 7886 2500)
Corporate Broking: David Watkins
Corporate Advisory: Atholl Tweedie
Berenberg (Tel: 020 3207 7800)
Investment Banking: James Felix, John Welch, Dan Gee-Summons
ENDS
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy. END ADMSSFSAEEMSEDW